Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase
Clinical trial NCT03531320 · COMPLETED
Trial details
- NCT number
- NCT03531320
- Sponsor
- InnoPharmax Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-06
- Primary completion
- 2020-12-28
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.